InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
T+90 hit rate
33%
T+90 mean return
-12.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Acosta Andrea, Vice-Président Général, Directrice Comptable. Insider active across 2 companies, notably Biomarin Pharmaceutical INC. Cumulatively, 42 filings have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1m. Activity tracked since 30 April 2021. The latest transaction was filed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations42 total
123,633 shares0Class A Common StockSEC:0001818518-26-000006:0
24,252 shares0Class A Common StockSEC:0001818518-26-000006:1
1,729 shares@ US$18.680.7% of flowClass A Common StockSEC:0001818518-26-000004:0
2,621 shares@ US$26.081.6% of flowClass A Common StockSEC:0001818518-25-000012:0
3,759 shares@ US$24.99682.2% of flowClass A Common StockSEC:0001818518-25-000010:0
7,592 shares@ US$24.81Class A Common StockSEC:0001818518-25-000008:0
2,620 shares@ US$35.812.1% of flowClass A Common StockSEC:0001818518-25-000006:0
3,759 shares@ US$34.96342.7% of flowClass A Common StockSEC:0001506293-25-000208:0
7,592 shares@ US$35.485.5% of flowClass A Common StockSEC:0001506293-25-000206:0
2,620 shares@ US$34.222.0% of flowClass A Common StockSEC:0001506293-25-000160:0
3,759 shares@ US$31.8642.8% of flowClass A Common StockSEC:0001506293-25-000121:0
7,592 shares@ US$32.265.8% of flowClass A Common StockSEC:0001506293-25-000114:0
35,420 shares0Class A Common StockSEC:0001506293-25-000089:0
1,725 shares@ US$31.421.3% of flowClass A Common StockSEC:0001506293-25-000056:0
3,941 shares@ US$35.753.5% of flowClass A Common StockSEC:0001506293-25-000044:0
8,716 shares0Class A Common StockSEC:0001506293-25-000039:0
3,667 shares@ US$37.4613.5% of flowClass A Common StockSEC:0001506293-25-000032:0
7,746 shares@ US$39.567.8% of flowClass A Common StockSEC:0001506293-25-000030:0
2,926 shares@ US$29.492.2% of flowClass A Common StockSEC:0001506293-24-000208:0
3,845 shares@ US$30.883.0% of flowClass A Common StockSEC:0001506293-24-000200:0
7,449 shares@ US$29.235.5% of flowClass A Common StockSEC:0001506293-24-000196:0
2,925 shares@ US$30.382.1% of flowClass A Common StockSEC:0001506293-24-000168:0
3,845 shares@ US$31.572.9% of flowClass A Common StockSEC:0001506293-24-000158:0
7,449 shares@ US$31.655.7% of flowClass A Common StockSEC:0001506293-24-000156:0
2,925 shares@ US$44.013.2% of flowClass A Common StockSEC:0001506293-24-000132:0
25 of 42 declarations
About Acosta Andrea
Acosta Andrea is the General Vice President and Chief Accounting Officer at BIOMARIN PHARMACEUTICAL INC and PINTEREST, INC. She is responsible for managing the accounting and financial operations of these companies. Her role involves overseeing financial reporting and ensuring compliance with accounting standards. She plays a key role in strategic decision-making to ensure the growth and profitability of the companies.
